United Therapeutics | UTHR - Sales Revenues


United Therapeutics reported $790.2M in Sales Revenues for its fiscal quarter ending in December of 2025.





Sales Change Date
Amarin USD 49.67M 23.07M Sep/2025
Ardelyx USD 110.33M 12.67M Sep/2025
Baxter International USD 2.97B 130M Dec/2025
Bayer EUR 11.44B 1.78B Dec/2025
BioCryst Pharmaceuticals USD 406.56M 247.16M Dec/2025
Biogen USD 2.28B 250M Dec/2025
BioMarin Pharmaceutical USD 875M 99M Dec/2025
Emergent BioSolutions USD 276.6M 6.1M Dec/2023
Esperion Therapeutics USD 168.45M 81.14M Dec/2025
Gilead Sciences USD 7.93B 130M Dec/2025
GlaxoSmithKline GBP 8.62B 73M Dec/2025
Halozyme Therapeutics USD 451.76M 97.76M Dec/2025
Insmed USD 263.8M 121.8M Dec/2025
Ionis Pharmaceuticals USD 203M 46M Dec/2025
J&J USD 24.6B 610M Dec/2025
Lexicon Pharmaceuticals USD 5.49M 8.69M Dec/2025
Moderna USD 678M 342M Dec/2025
Pfizer USD 17.58B 880M Dec/2025
PTC Therapeutics USD 164.7M 46.3M Dec/2025
Regeneron Pharmaceuticals USD 3.88B 130M Dec/2025
Sangamo BioSciences USD 356K 125K Jun/2024
Sarepta Therapeutics USD 442.9M 43.5M Dec/2025
Teva Pharmaceutical Industries USD 14.63B 10M Dec/2025
United Therapeutics USD 790.2M 9.3M Dec/2025
Vertex Pharmaceuticals USD 3.19B 110M Dec/2025